SAFETY AND PLASMA ANTI-XA LEVELS OF LOW-MOLECULAR-WEIGHT HEPARIN INITIATED PRIOR TO STREPTOKINASE IN PATIENTS WITH ACUTE MYOCARDIAL-INFARCTION

被引:0
|
作者
GORANSSON, L [1 ]
NILSEN, DWT [1 ]
LARSEN, AI [1 ]
HETLAND, O [1 ]
SULILA, P [1 ]
机构
[1] CENT HOSP ROGALAND,DIV CARDIOL,STAVANGER,NORWAY
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:648 / 648
页数:1
相关论文
共 50 条
  • [1] LOW-MOLECULAR-WEIGHT HEPARIN INITIATED SUBCUTANEOUSLY PRIOR TO STREPTOKINASE DID NOT MODIFY SYSTEMIC THROMBIN ACTIVITY IN PATIENTS WITH ACUTE MYOCARDIAL-INFARCTION
    NILSEN, DWT
    GORANSSON, L
    LARSEN, AI
    SULILA, P
    KIERULF, P
    [J]. THROMBOSIS AND HAEMOSTASIS, 1993, 69 (06) : 651 - 651
  • [2] Anti-Xa levels with low molecular weight heparin (Fraxiparin) and thrombolytic therapy for acute myocardial infarction
    deWinter, RJ
    Levi, M
    Chamuleau, SAJ
    Adams, R
    Buller, HR
    Prins, M
    Peters, RJG
    [J]. THROMBOSIS AND HAEMOSTASIS, 1997, : P1168 - P1168
  • [3] Stability of Plasma Anti-Xa Activity in Low-Molecular-Weight Heparin Monitoring
    Rojnuckarin, Ponlapat
    Akkawat, Benjaporn
    Juntiang, Jumlong
    [J]. CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2010, 16 (03) : 313 - 317
  • [4] Anti-Xa monitoring of low-molecular-weight heparin in adult patients with cancer
    Kreuziger, Lisa Baumann
    Streiff, Michael
    [J]. HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2016, : 206 - 207
  • [5] SUBCUTANEOUS LOW-MOLECULAR-WEIGHT HEPARIN VERSUS UNFRACTIONATED HEPARIN IN ACUTE MYOCARDIAL-INFARCTION
    BRANZI, A
    CERVI, V
    MELANDRI, G
    SEMPRINI, F
    FINI, M
    [J]. ATHEROSCLEROSIS VIII, 1989, 817 : 443 - 445
  • [6] THE ANTI-XA ACTIVITY OF DESMIN 370 IS ATTRIBUTABLE TO LOW-MOLECULAR-WEIGHT HEPARIN
    BRIEGER, D
    DAWES, J
    [J]. THROMBOSIS AND HAEMOSTASIS, 1995, 73 (06) : 1351 - 1351
  • [7] THE EFFECT OF PLASMA-PROTEINS ON THE ANTI-IIA AND ANTI-XA ACTIVITIES OF STANDARD HEPARIN AND LOW-MOLECULAR-WEIGHT HEPARIN
    COSMI, B
    WEITZ, JI
    HIRSH, J
    [J]. CIRCULATION, 1992, 86 (04) : 869 - 869
  • [8] Anti-Xa Monitoring of Low-Molecular-Weight Heparin during Pregnancy: A Systematic Review
    Kjaergaard, Amalie Baun
    Fuglsang, Jens
    Hvas, Anne-Mette
    [J]. SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2021, 47 (07): : 824 - 842
  • [9] Routine Plasma Anti-Xa Monitoring is Required for Low-Molecular-Weight Heparins
    Hesham S. Al-Sallami
    Michael A. Barras
    Bruce Green
    Stephen B. Duffull
    [J]. Clinical Pharmacokinetics, 2010, 49 : 567 - 571
  • [10] Routine Plasma Anti-Xa Monitoring is Required for Low-Molecular-Weight Heparins
    Al-Sallami, Hesham S.
    Barras, Michael A.
    Green, Bruce
    Duffull, Stephen B.
    [J]. CLINICAL PHARMACOKINETICS, 2010, 49 (09) : 567 - 571